Reconstituting National Institute for Biological Standards and Control (NIBSC) chemokines

Margaret E Hoadley1, Sylvia Scarth, Stephen J Hopkins

  • 1Brain Injury Research Group, Clinical Sciences Building, Salford Royal Foundation Trust, Salford M6 8HD, UK. margaret.hoadley@manchester.ac.uk

Cytokine
|February 28, 2012
PubMed

Insights

Discrepancies in immunoassay results for interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) were linked to preparation methods. Early protein addition is crucial to prevent loss of immunoreactivity during chemokine sample preparation.

Area of Science:

  • Biochemistry
  • Immunology
  • Analytical Chemistry

Background:

  • Immunoassay results for cytokines like IL-8 and MCP-1 can vary significantly.
  • Internal reference preparations from institutions like NIBSC may exhibit discrepancies.
  • Chemokine stability is critical for accurate quantification in biological samples.

Purpose of the Study:

  • To investigate the causes of discrepancies in immunoassay results for IL-8 and MCP-1.
  • To determine the impact of preparation diluents and protein incorporation timing on chemokine stability.
  • To establish best practices for preparing chemokine reference materials to ensure assay reliability.

Main Methods:

  • Chemokine preparations (IL-8, MCP-1) were made using diluents with varying protein addition steps.
  • Immunoreactivity of prepared chemokines was assessed using immunoassays.
  • The effect of water exposure on chemokine preparations without added protein was evaluated.

Main Results:

  • Significant discrepancies were observed between immunoassay results using different reference preparations.
  • Even brief exposure to water, without additional protein, led to a loss of immunoreactivity.
  • The timing of protein incorporation during sample preparation directly influenced chemokine stability and assay performance.

Conclusions:

  • Early incorporation of protein into diluents is essential for maintaining chemokine integrity.
  • Improper sample preparation, particularly inadequate protein stabilization, can lead to significant loss of immunoreactivity.
  • Standardized protocols emphasizing early protein addition are vital for reliable IL-8 and MCP-1 immunoassay results.

Related Concept Videos